Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
1.230
-0.055 (-4.28%)
At close: May 19, 2025, 4:00 PM
1.260
+0.030 (2.44%)
After-hours: May 19, 2025, 6:53 PM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $348.44 million as of May 19, 2025. Its market cap has increased by 7.24% in one year.
Market Cap
348.44M
Enterprise Value
-11.82M
1-Year Change
7.24%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $348.44M, a decrease of -81.25%. That is a compound annual growth rate of -35.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 348.44M | -50.90% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.89B |
| Johnson & Johnson | 366.90B |
| AbbVie | 328.04B |
| Novo Nordisk | 293.82B |
| UnitedHealth Group | 286.56B |
| Abbott Laboratories | 235.83B |
| Novartis AG | 215.48B |
| AstraZeneca | 214.95B |